StocksFin Logo
BCRX logo
$BCRX

BioCryst Pharmaceuticals, Inc.

BCRX country of incorporation
|
https://www.biocryst.com
|
Mr. Jon Stonehouse
|
358 employees
NASDAQ | Healthcare | Biotechnology
BCRX reported its Q322 earnings on November 4, 2022 (98 weeks ago).
$75.83M 85% vs. Q321 Revenues Q322
95.24% -3.3% vs. Q321 Gross Profit Margin
-56.08% ! 60.9% vs. Q321 Net Profit Margin
-32.62M ! -38% vs. Q321 Free Cash Flow Q322
$-0.23 ! 30.3% vs. Q321 EPS Q322
Company Card Q322
As reported on November 4, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 4, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
75.83M
+15.7%
3.61M
-42.52M
+27.8%
$-0.23
Q22022
65.53M
+31.3%
247k
-58.86M
+20.7%
$-0.32
Q12022
49.92M
238k
-74.2M
$-0.4
FY2021
157.17M
 7.26M
-184.06M
$-1.03
Q42021
47.16M
+15%
419k
-17.78M
+69.8%
$-0.1
Q32021
40.99M
-17.9%
615k
-58.8M
-36.1%
$-0.33
Q22021
49.96M
+162.1%
343k
-43.2M
+32.8%
$-0.24
Q12021
19.06M
5.92M
-64.28M
$-0.36
FY2020
17.81M
 1.68M
-182.81M
$-1.09
FY2019
48.84M
 4.1M
-108.9M
$-0.94
FY2018
20.65M
 471k
-101.25M
$-0.98
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
558.59M
 801.25M
246.9M
721.81M
-242.66M
Q22022
510.54M
 723.77M
272.57M
152.85M
-213.23M
Q12022
527.72M
 691.94M
395.5M
613M
-164.22M
FY2021
588.15M
 695.14M
504.39M
595.06M
-106.99M
FY2020
334.72M
 353.98M
272.13M
306.81M
-19.26M
FY2019
175.28M
 137.03M
114.17M
121.21M
38.25M
FY2018
146.84M
 97.61M
26.73M
92.87M
49.24M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
-32.44M
 -69.54M
76.33M
-175k
-32.62M
-16.5%
Q22022
-27.76M
 -97.44M
147k
-244k
-28M
+64.2%
Q12022
-77.8M
 -38.47M
7.36M
-406k
-78.21M
FY2021
-142.16M
 15.8M
359.67M
-2.39M
-144.54M
FY2020
-137.22M
 -6.86M
302.7M
-514k
-137.73M
FY2019
-89.58M
 77.93M
99.1M
-343k
-89.93M
FY2018
-92.57M
 4.77M
62.5M
-366k
-92.93M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees